6533b7d5fe1ef96bd1263cf4

RESEARCH PRODUCT

Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: Let's leave the doubts behind

Rafael De La EspriellaJulio NúñezAntoni Bayes-genis

subject

Heart Failuremedicine.medical_specialtybusiness.industrymedicine.diseaseRenin-Angiotensin SystemInternal medicineHeart failureCardiologyHumansMedicineNeprilysinCardiology and Cardiovascular MedicinebusinessNeprilysinRandomized Controlled Trials as Topichttps://doi.org/10.1016/j.ijcard.2019.09.023